ArticleJournal of neuroimmunology2015

Favorable outcome of granulocyte colony-stimulating factor use in neuromyelitis optica patients presenting with agranulocytosis in the setting of rituximab.

Maureen A Mealy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.